BIIB
USDBiogen Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$155.700
Máximo
$156.220
Mínimo
$154.010
Volume
1.72M
Fundamentos da empresa
Capitalização de mercado
22.7B
Setor
Drug Manufacturers - General
País
United States
Estatísticas de negociação
Volume médio
1.64M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157
Bernstein analyst William Pickering maintains Biogen with a Market Perform and raises the price target from $155 to $157.
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210
RBC Capital analyst Brian Abrahams maintains Biogen with a Outperform and lowers the price target from $217 to $210.
Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline
Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple sclerosis treatments.
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.